Arcus Biosciences RCUS
NYSE RCUS
$24.46 -0.76 (-3.01%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2026)

Updated

Arcus Biosciences' Interest & Investment Income came in at $8 million for Q2 2026, down 20.0% from $10 million a year earlier and down 11.1% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) Interest & Investment Income (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Arcus Biosciences reported Interest & Investment Income of $37 million, down 21.3% year-over-year; for FY2025, it came in at $41 million, down 21.2% from FY2024.

  • Interest & Investment Income carries a five-year compound annual growth rate of 110.2% (FY2020 to FY2025).
  • Going back by year, Interest & Investment Income was $52 million in FY2024 (+26.8%), $41 million in FY2023 (+156.3%), $16 million in FY2022 and $1 million in FY2021 (unchanged).
  • The five-year range for quarterly Interest & Investment Income is $161,000 (Q3 2021) to $14 million (Q3 2024).
  • Year-over-year, Interest & Investment Income has declined for six consecutive quarters, with an average decline of 12.0% over the last eight quarters.
  • The fastest year-over-year change in Interest & Investment Income over five years came in Q1 2022 (growth of 277.9%), and the weakest in Q3 2021 (a decline of 40.4%).
  • Business Quant data shows RCUS's Interest & Investment Income at $9 million (Q1 2026), $10 million (Q4 2025) and $10 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Arcus Biosciences 3.11 Bn -229.58 Mn - 8.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.00 Mn
Mar 31, 2026 9.00 Mn
Dec 31, 2025 10.00 Mn
Sep 30, 2025 10.00 Mn
Jun 30, 2025 10.00 Mn
Mar 31, 2025 11.00 Mn
Dec 31, 2024 12.00 Mn
Sep 30, 2024 14.00 Mn
Jun 30, 2024 13.00 Mn
Mar 31, 2024 13.00 Mn
Dec 31, 2023 11.00 Mn
Sep 30, 2023 12.00 Mn
Jun 30, 2023 9.00 Mn
Mar 31, 2023 9.00 Mn
Dec 31, 2022 8.00 Mn
Sep 30, 2022 5.00 Mn
Jun 30, 2022 3.00 Mn
Mar 31, 2022 582,000.00
Dec 31, 2021 519,000.00
Sep 30, 2021 161,000.00
API Access

Arcus Biosciences Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=RCUS&period=max&api_key=YOUR_API_KEY